BETH PSAILA, M.D., PHD

Associate Professor of Haematology, Univ. of Oxford

CRUK Advanced Clinical Scientist

Haematology Consultant, Churchill Hospital 

Senior Fellow, New College Oxford

Beth is a Group Leader at the MRC Weatherall Institute of Molecular Medicine and a haematology consultant specialising in the care of patients with myeloproliferative neoplasms. Before Oxford, she trained at Clare College, Cambridge University, University College London Hospitals and The Hammersmith Hospital/Imperial College London and also spent >6 years in the US at Cornell University, New York and the National Human Genome Research Institute, National Institutes of Health, Bethesda. She has been studying megakaryocytes/platelets and haematopoiesis for >15 years, leading to a strong national and international research network. She is passionate about translational science, motivated to apply state-of-the-art techniques to better understand mechanisms of disease in her patients, identify new therapeutic strategies and develop more clinically relevant models for target validation.  

Beth is highly committed to training and mentoring. Alumni from her group have an excellent track record in securing personal fellowships, independent grant funding and positions in industry. Together with Adam Mead, she is a co-founder of Alethiomics, a recent spin-out company from the WIMM. 

​

Outside of work, she enjoys adventures with her husband and three children, and escaping for runs around beautiful Oxford with her over-enthusiastic but surprisingly obedient cockapoo. 

ABDULLAH KHAN, PHD

Sir Henry Wellcome Postdoctoral Fellow
Institute of Cardiovascular Sciences, Birmingham
& Psaila Lab, MRC WIMM Oxford

Abs Khan is a Henry Wellcome Fellow. 

His background is in CRISPR gene editing and super-resolution microscopy. His fellowship has been focused on developing physiologically relevant, 3D models using induced pluripotent stem cells (iPSCs). He led our recent work published in Cancer Discovery developing and validating an iPSC-derived bone marrow organoids platform for disease modelling, target discovery and validation. 

CAMELIA BENLABIOD, PHD

Postdoctoral Researcher

Camelia recently joined us from Gustave Roussy, Paris where she completed her PhD with Caroline Marty and Isabel Plo studying the mechanisms of action and phenotypic differences between the two common types of mutations in calreticulin in Myeloproliferative Neoplasms. We are thrilled that she has joined our group, and she will be working on developing new models of myeloproliferative neoplasms.

RONG LI, PHD

Chinese Academy of Medical Sciences Senior Postdoctoral Fellow, Psaila Lab

Rong is using single cell approaches to study mechanisms of inflammation and fibrosis in myelofibrosis using primary patient cells and in vivo/in vitro systems. She was awarded a prestigious Chinese Academy of Medical Sciences Fellowship to focus on immune cells in MPNs, working in collaboration between the Psaila lab and that of Professor Tao Dong, Human Immunology Unit, MRC WIMM.

NATALIE JOOSS, PHD